Letter: proving the benefit of exercise intervention in non-alcoholic fatty liver disease
- PMID: 33105976
- DOI: 10.1111/apt.16064
Letter: proving the benefit of exercise intervention in non-alcoholic fatty liver disease
Comment in
-
Letter: proving the benefit of exercise intervention in metabolic associated fatty liver disease-authors' reply.Aliment Pharmacol Ther. 2020 Oct;52(8):1426-1427. doi: 10.1111/apt.16070. Aliment Pharmacol Ther. 2020. PMID: 33105979 No abstract available.
Comment on
-
Improvement in histological endpoints of MAFLD following a 12-week aerobic exercise intervention.Aliment Pharmacol Ther. 2020 Oct;52(8):1387-1398. doi: 10.1111/apt.15989. Epub 2020 Jul 27. Aliment Pharmacol Ther. 2020. PMID: 32717123 Clinical Trial.
References
REFERENCES
-
- O’Gorman P, Naimimohasses S, Monaghan A, et al. Improvement in histological endpoints of MAFLD following a 12-week aerobic exercise intervention. Aliment Pharmacol Ther. 2020;52:1387-1398.
-
- Hickman IJ, Byrne NM, Croci I, et al. A pilot randomised study of the metabolic and histological effects of exercise in non-alcoholic steatohepatitis. J Diabetes Metab. 2013;4:300. https://doi.org/10.4172/2155-6156.1000300
-
- Eckard C, Cole R, Lockwood J, et al. Prospective histopathologic evaluation of lifestyle modification in nonalcoholic fatty liver disease: a randomized trial. Therap Adv Gastroenterol. 2013;6:249-259.
-
- Stine JG, Schreibman I, Navabi S, et al. Nonalcoholic steatohepatitis fitness intervention in thrombosis (NASHFit): Study protocol for a randomized controlled trial of a supervised aerobic exercise program to reduce elevated clotting risk in patients with NASH. Contemp Clin Trials Commun 2020;18:100560.
-
- Stine JG, Xu D, Schmitz K, Sciamanna C, Kimball SR. Exercise attenuates ribosomal protein six phosphorylation in fatty liver disease. Dig Dis Sci. 2020. [Epub ahead of print]. https://doi.org/10.1007/s10620-020-06226-1
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical